Identification of Atrial Fibrillation in Secondary Care Diabetes and Vascular Clinics: A Pilot Study

References

• Miyasaka Y , BarnesME, GershBJet al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation, 114(2), 119–125 (2006).
   PubMed Web of Science ®Google Scholar
• Wolf PA , AbbottRD, KannelWB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke, 22(8), 983–988 (1991).
   PubMed Web of Science ®Google Scholar
• Santiago D , WarshofskyM, LiMandri Get al. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. J. Am. Coll. Cardiol., 24(1), 159–164 (1994).
   PubMed Web of Science ®Google Scholar
• Nattel S . New ideas about atrial fibrillation 50 years on. Nature, 415(6868), 219–226 (2002).
   PubMed Web of Science ®Google Scholar
• Friberg L , RosenqvistM, LindgrenA, TerentA, NorrvingB, AsplundK. High prevalence of atrial fibrillation among patients with ischemic stroke. Stroke, 45(9), 2599–2605 (2014).
   PubMed Web of Science ®Google Scholar
• Marinigh R , LipGY, FiottiN, GiansanteC, LaneDA. Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. J. Am. Coll. Cardiol., 56(11), 827–837 (2010).
   PubMed Web of Science ®Google Scholar
• Kirchhof P , BenussiS, KotechaDet al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace, 18(11), 1609–1678 (2016).
   PubMed Web of Science ®Google Scholar
• Lip GY , NieuwlaatR, PistersR, LaneDA, CrijnsHJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart survey on atrial fibrillation. Chest, 137(2), 263–272 (2010).
   PubMed Web of Science ®Google Scholar
• Hart RG , PearceLA, AguilarMI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann. Intern. Med., 146(12), 857–867 (2007).
   PubMed Web of Science ®Google Scholar
• Lip GY , FrisonL, HalperinJL, LaneDA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile INR, elderly, drugs/alcohol concomitantly) score. J. Am. Coll. Cardiol., 57(2), 173–180 (2011).
   PubMed Web of Science ®Google Scholar
• Roger VL , GoAS, Lloyd-JonesDMet al. Heart Disease and Stroke Statistics – 2012 update: a report from the American Heart Association. Circulation, 125(1), e2–e220 (2012).
   PubMed Web of Science ®Google Scholar
• Wolf PA , MitchellJB, BakerCS, KannelWB, D’AgostinoRB. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch. Intern. Med., 158(3), 229–234 (1998).
   PubMedGoogle Scholar
• Go AS , HylekEM, PhillipsKAet al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA, 285(18), 2370–2375 (2001).
   PubMed Web of Science ®Google Scholar
• Chugh SS , BlackshearJL, ShenWK, HammillSC, GershBJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J. Am. Coll. Cardiol., 37(2), 371–378 (2001).
   PubMed Web of Science ®Google Scholar
• Savelieva I , CammAJ. Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J. Interv. Card. Electrophysiol., 4(2), 369–382 (2000).
   PubMed Web of Science ®Google Scholar
• Chatap G , GiraudK, VincentJP. Atrial fibrillation in the elderly: facts and management. Drugs Aging, 19(11), 819–846 (2002).
   PubMed Web of Science ®Google Scholar
• Aronow WS . Management of the older person with atrial fibrillation. J. Gerontol. A Biol. Sci. Med. Sci., 57(6), M352–363 (2002).
   PubMed Web of Science ®Google Scholar
• Halcox JPJ , WarehamK, CardewAet al. Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study. Circulation, 136(19), 1784–1794 (2017).
   PubMed Web of Science ®Google Scholar
• Orchard J , FreedmanSB, LowresN, PeirisD, NeubeckL. iPhone ECG screening by practice nurses and receptionists for atrial fibrillation in general practice: the GP-SEARCH qualitative pilot study. Aust. Fam. Physician, 43(5), 315–319 (2014).
   PubMedGoogle Scholar
• Lowres N , NeubeckL, SalkeldGet al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb. Haemost., 111(6), 1167–1176 (2014).
   PubMed Web of Science ®Google Scholar
• Grubb NR , ElderD, BroadhurstP, ReochA, TassieE, NeilsonA. Atrial fibrillation case finding in over 65s with cardiovascular risk factors - Results of initial Scottish clinical experience. Int. J. Cardiol., 288, 94–99 (2019).
   PubMed Web of Science ®Google Scholar
• Sorbets E , FoxKM, ElbezYet al. Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry. Eur. Heart J., 41(3), 347–356 (2019).
   Web of Science ®Google Scholar
• Vrsalović M , PresečkiAV. Atrial fibrillation and risk of cardiovascular events and mortality in patients with symptomatic peripheral artery disease: ameta-analysis of prospective studies. In: Clin. Cardiol., 40(12), 1231–1235 (2017).
   PubMed Web of Science ®Google Scholar
• Huxley RR , AlonsoA, LopezFLet al. Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the atherosclerosis risk in communities study. Heart, 98(2), 133–138 (2012).
   PubMed Web of Science ®Google Scholar
• Kim YG , HanKD, ChoiJIet al. The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study. Cardiovasc. Diabetol., 18(1), 128 (2019).
   PubMed Web of Science ®Google Scholar
• Fangel MV , NielsenPB, KristensenJKet al. Glycemic status and thromboembolic risk in patients with atrial fibrillation and type 2 diabetes mellitus. Circ. Arrhythm. Electrophysiol., 12(5), e007030 (2019).
   PubMed Web of Science ®Google Scholar
• Echouffo-Tcheugui JB , ShraderP, ThomasLet al. Care patterns and outcomes in atrial fibrillation patients with and without diabetes: ORBIT-AF registry. J. Am. Coll. Cardiol., 70(11), 1325–1335 (2017).
   PubMed Web of Science ®Google Scholar
• Hicks L , NewtonJ, NayarR, MackayK. Empowering podiatrists to perform pulse checks for opportunistic atrial fibrillation detection during annual diabetes foot checks. Open Heart., 6(1), e000795 (2019).
   PubMed Web of Science ®Google Scholar
• Chan PH , WongCK, PohYCet al. Diagnostic performance of a smartphone-based photoplethysmographic application for atrial fibrillation screening in a primary care setting. J. Am. Heart Assoc., 5(7), e003428 (2016).
   PubMed Web of Science ®Google Scholar
• Jani BD , NichollBI, McQueenieRet al. Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort. Europace, 20(Fi_3), f329–f336 (2018).
   PubMedGoogle Scholar
• Van Den Ham HA , KlungelOH, SingerDE, LeufkensHG, Van StaaTP. Comparative performance of ATRIA, CHADS2, and CHA2DS2-VASc risk scores predicting stroke in patients with atrial fibrillation: results from a national primary care database. J. Am. Coll. Cardiol., 66(17), 1851–1859 (2015).
   PubMed Web of Science ®Google Scholar
• Pisters R , LaneDA, NieuwlaatR, DeVos CB, CrijnsHJ, LipGY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart survey. Chest, 138(5), 1093–1100 (2010).
   PubMed Web of Science ®Google Scholar
• Lau JK , LowresN, NeubeckLet al. iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int. J. Cardiol., 165(1), 193–194 (2013).
   PubMed Web of Science ®Google Scholar
• Davis RC , HobbsFD, KenkreJEet al. Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study. Europace, 14(11), 1553–1559 (2012).
   PubMed Web of Science ®Google Scholar
• Fleisher LA , BeckmanJA, BrownKAet al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation, 116(17), e418–499 (2007).
   PubMed Web of Science ®Google Scholar
• Savelieva I , CammAJ. Silent atrial fibrillation – another Pandora’s box. Pacing Clin. Electrophysiol., 23(2), 145–148 (2000).
   PubMed Web of Science ®Google Scholar
• Flint AC , BankiNM, RenX, RaoVA, GoAS. Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) registry. Stroke, 43(10), 2788–2790 (2012).
   PubMed Web of Science ®Google Scholar
• Grond M , JaussM, HamannGet al. Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study. Stroke, 44(12), 3357–3364 (2013).
   PubMed Web of Science ®Google Scholar
• Sanna T , DienerHC, PassmanRSet al. Cryptogenic stroke and underlying atrial fibrillation. N. Engl. J. Med., 370(26), 2478–2486 (2014).
   PubMed Web of Science ®Google Scholar
• Doliwa Sobocinski P , AnggardhRooth E, FrykmanKull V, Von ArbinM, WallenH, RosenqvistM. Improved screening for silent atrial fibrillation after ischemic stroke. Europace, 14(8), 1112–1116 (2012).
   PubMed Web of Science ®Google Scholar
• Svennberg E , EngdahlJ, Al-KhaliliF, FribergL, FrykmanV, RosenqvistM. Mass screening for untreated atrial fibrillation: The STROKESTOP study. Circulation, 131(25), 2176–2184 (2015).
   PubMed Web of Science ®Google Scholar
• Walsh JA , TopolEJ, SteinhublSR. Novel wireless devices for cardiac monitoring. Circulation, 130(7), 573–581 (2014).
   PubMed Web of Science ®Google Scholar
• Wilson J , JungerG. Principles and practice of screening for disease. Public health papers, no 34. World Health Organization, Geneva, Switzerland (1968). www.who.int/bulletin/volumes/86/4/07-050112BP.pdf
   Google Scholar
• Medi C , HankeyGJ, FreedmanSB. Stroke risk and antithrombotic strategies in atrial fibrillation. Stroke, 41(11), 2705–2713 (2010).
   PubMed Web of Science ®Google Scholar
• Connolly SJ , EzekowitzMD, YusufSet al. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med., 361(12), 1139–1151 (2009).
   PubMed Web of Science ®Google Scholar
• Granger CB , AlexanderJH, McMurrayJJet al. Apixaban versus warfarin in patients with atrial fibrillation. N. Engl. J. Med., 365(11), 981–992 (2011).
   PubMed Web of Science ®Google Scholar
• Chan NY . Systematic screening for atrial fibrillation in the community: evidence and obstacles. Arrhythm. Electrophysiol. Rev., 7(1), 39–42 (2018).
   PubMedGoogle Scholar
• Lowres N , OlivierJ, ChaoTFet al. Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals. PLoS Med, 16(9), e1002903 (2019).
   PubMed Web of Science ®Google Scholar
• Kaura A , SztrihaL, ChanFKet al. Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial. Eur. J. Med. Res., 24, 25 (2019).
   PubMed Web of Science ®Google Scholar